# Revivicor

its 10-gene-edited UHeart received FDA clearance to proceed with the EXPRESS clinical trial, an adaptive Phase 1/2/3 design for pig-heart xenotransplantation, following the first-ever living-patient pig-heart transplants performed under FDA expanded access.

Source: https://en.bioecon.ru/companies/revivicor/
Updated: 2026-07-03

- Country: United States

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Regulatory approval | FDA clearance to proceed with the EXPRESS clinical trial for UHeart xenotransplantation granted May 15, 2026 | https://investingnews.com/united-therapeutics-corporation-announces-fda-clearance-to-proceed-with-uheart-xenotransplantation-clinical-trial/, https://ir.unither.com/press-releases/2026/05-15-2026-230017490, https://ir.unither.com/~/media/Files/U/United-Therapeutics-IR/documents/press-releases/2026/uthr-announces-fda-clearance-to-proceed-with-uheart-xenotransplantation-clinical-trial.pdf |
| Production site | Clinical-scale, pathogen-free facility in Christiansburg, Virginia | https://apnews.com/article/pig-organ-transplant-xenotransplant-revivicor-ad400e7f1d30c2722456eb92e641449f, https://www.vtcrc.com/gene-editing-pigs-for-human-transplants/ |
| Capacity | Approximately 125 organs per year in Christiansburg facility | https://apnews.com/article/pig-organ-transplant-xenotransplant-revivicor-ad400e7f1d30c2722456eb92e641449f, https://www.vtcrc.com/gene-editing-pigs-for-human-transplants/ |
| Revenue | $783.3 million for the second quarter of 2026 | https://ir.unither.com/press-releases/2026/08-05-2026-113027315, https://ir.unither.com/~/media/Files/U/United-Therapeutics-IR/documents/press-releases/2026/2q26-earnings-release.pdf |
| Headcount | More than 1,400 employees as of December 31, 2025 [medium confidence] | https://ir.unither.com/~/media/Files/U/United-Therapeutics-IR/documents/events-and-presentations/factsheet-2q26.pdf, https://ir.unither.com/~/media/Files/U/United-Therapeutics-IR/documents/press-releases/2026/4q25-factsheet.pdf |

Independent sources: apnews.com, investingnews.com, ir.unither.com, vtcrc.com

## Technologies

- [Xenotransplantation](https://en.bioecon.ru/technology/xenotransplantation/)